DE69107026D1 - Injizierbare galenische retardzubereitung. - Google Patents

Injizierbare galenische retardzubereitung.

Info

Publication number
DE69107026D1
DE69107026D1 DE69107026T DE69107026T DE69107026D1 DE 69107026 D1 DE69107026 D1 DE 69107026D1 DE 69107026 T DE69107026 T DE 69107026T DE 69107026 T DE69107026 T DE 69107026T DE 69107026 D1 DE69107026 D1 DE 69107026D1
Authority
DE
Germany
Prior art keywords
carrier
drug
microspheres
recipient
injectable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69107026T
Other languages
English (en)
Other versions
DE69107026T2 (de
Inventor
Uribe Juan Angeles
Garza Josue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aplicaciones Farmaceuticas SA de CV
Original Assignee
Aplicaciones Farmaceuticas SA de CV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aplicaciones Farmaceuticas SA de CV filed Critical Aplicaciones Farmaceuticas SA de CV
Application granted granted Critical
Publication of DE69107026D1 publication Critical patent/DE69107026D1/de
Publication of DE69107026T2 publication Critical patent/DE69107026T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
DE69107026T 1990-06-14 1991-06-12 Injizierbare galenische retardzubereitung. Expired - Fee Related DE69107026T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9007417A FR2663224B1 (fr) 1990-06-14 1990-06-14 Forme galenique parenterale.
PCT/EP1991/001097 WO1991019485A1 (fr) 1990-06-14 1991-06-12 Forme galenique injectable retardee

Publications (2)

Publication Number Publication Date
DE69107026D1 true DE69107026D1 (de) 1995-03-09
DE69107026T2 DE69107026T2 (de) 1995-08-31

Family

ID=9397599

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69107026T Expired - Fee Related DE69107026T2 (de) 1990-06-14 1991-06-12 Injizierbare galenische retardzubereitung.

Country Status (33)

Country Link
US (1) US5643604A (de)
EP (1) EP0487674B1 (de)
JP (1) JP2690398B2 (de)
KR (1) KR0157438B1 (de)
CN (1) CN1058608C (de)
AT (1) ATE117546T1 (de)
AU (1) AU643540B2 (de)
BG (1) BG61178B1 (de)
BR (1) BR9105782A (de)
CA (1) CA2064861C (de)
CZ (1) CZ286199B6 (de)
DE (1) DE69107026T2 (de)
DK (1) DK0487674T3 (de)
ES (1) ES2068592T3 (de)
FI (1) FI107697B (de)
FR (1) FR2663224B1 (de)
GR (1) GR3015809T3 (de)
HU (1) HU219461B (de)
IE (1) IE69172B1 (de)
IL (1) IL98458A (de)
NO (2) NO302927B1 (de)
NZ (1) NZ238543A (de)
PH (1) PH30243A (de)
PL (1) PL167177B1 (de)
PT (1) PT97976B (de)
RO (1) RO110198B1 (de)
RU (1) RU2095055C1 (de)
SK (1) SK279867B6 (de)
TN (1) TNSN91047A1 (de)
TW (1) TW205511B (de)
UY (1) UY23239A1 (de)
WO (1) WO1991019485A1 (de)
ZA (1) ZA914549B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6416778B1 (en) 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
CZ20013455A3 (cs) 1999-03-26 2003-02-12 Pozen Inc. Vysoce účinné dihydroergotaminové prostředky
ATE288687T1 (de) * 2001-09-27 2005-02-15 Cognis Deutschland Gmbh Kugelförmige sterinzubereitungen, deren herstellung und verwendung
AU2002336653A1 (en) * 2001-10-24 2003-05-06 Luciano Mastronardi Management of postoperative pain
EP1455697A4 (de) * 2001-12-20 2009-08-05 Femmepharma Holding Co Inc Vaginale verabreichung von arzneimitteln
US7655618B2 (en) * 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
CA2509755A1 (en) * 2002-12-27 2004-07-22 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
JP2006515026A (ja) * 2003-01-02 2006-05-18 フェムファーマ ホールディング カンパニー， インコーポレイテッド 乳房の疾患および障害の処置のための薬学的調製物
MX2008014654A (es) * 2003-06-13 2009-03-09 John Claude Savoir Formulacion de liberacion lenta de estradiol-progesterona para anticoncepción y terapia de remplazo hormonal.
US7413690B1 (en) 2003-10-29 2008-08-19 The University Of Mississippi Process and apparatus for producing spherical pellets using molten solid matrices
US7932249B2 (en) 2005-01-05 2011-04-26 Eli Lilly And Company Olanzapine pamoate dihydrate
WO2007072491A2 (en) * 2005-12-21 2007-06-28 Baskaran Chandrasekar Sustained release pharmaceutical formulation and treatment of ischemic heart disease by administering the same
CA2670636A1 (en) 2006-11-27 2008-06-05 H. Lundbeck A/S Heteroaryl amide derivatives
EP2104489A2 (de) * 2006-12-26 2009-09-30 FemmePharma Holding Company, Inc. Topische verabreichung von danazol
WO2009128692A1 (es) 2008-04-14 2009-10-22 Posi Visionary Solutions Llp Método y composición farmacéutica para lograr niveles plasmáticos de progesterona requeridos para diferentes indicaciones terapéuticas
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
BR112012017136B1 (pt) * 2010-01-14 2021-05-25 Umecrine Mood Ab composição farmacêutica compreendendo 3-beta-hidróxi5-alfa-pregnan-20-ona, colesterol e uma mistura de acilgliceróis, método para preparar dita composição farmacêutica, bem como usos da mesma para o tratamento ou prevenção de condições do sistema nervoso central e para cessar a anestesia induzida por esteroide
RU2576236C1 (ru) * 2014-08-22 2016-02-27 Александр Александрович Кролевец Способ получения нанокапсул антибиотиков в агар-агаре
RU2577689C1 (ru) * 2014-08-26 2016-03-20 Александр Александрович Кролевец Способ получения нанокапсул антибиотиков в агар-агаре
RU2578408C1 (ru) * 2014-09-10 2016-03-27 Александр Александрович Кролевец Способ получения нанокапсул алкалоидов
ITUB20153652A1 (it) * 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE744162A (fr) * 1969-01-16 1970-06-15 Fuji Photo Film Co Ltd Procede d'encapsulage
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3937668A (en) * 1970-07-15 1976-02-10 Ilse Zolle Method for incorporating substances into protein microspheres
DK123067B (da) * 1970-09-25 1972-05-15 Niro Atomizer As Fremgangsmåde til behandling af et pulverformigt, fedtholdigt mælkeprodukt.
JPS5017525A (de) * 1973-06-14 1975-02-24
US3982537A (en) * 1974-12-30 1976-09-28 Louis Bucalo Dynamic implants and method for implanting the same
CA1077842A (en) * 1975-10-09 1980-05-20 Minnesota Mining And Manufacturing Company Albumin medicament carrier system
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
US4357259A (en) * 1977-08-01 1982-11-02 Northwestern University Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4331654A (en) * 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
FR2524312B1 (fr) * 1982-04-01 1985-10-04 Tech Cuir Centre Nouvelles formes de micro-encapsulation de substances medicamenteuses par des couches homogenes de collagene natif
US4492720A (en) * 1983-11-15 1985-01-08 Benjamin Mosier Method of preparing microspheres for intravascular delivery
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
JPS61174940A (ja) * 1985-01-29 1986-08-06 Oogawara Kakoki Kk ワックス類コーテイング単核状マイクロカプセルおよびその製造方法
US4675173A (en) * 1985-05-08 1987-06-23 Molecular Biosystems, Inc. Method of magnetic resonance imaging of the liver and spleen
IL79407A (en) * 1985-08-01 1991-03-10 Theragenics Corp System and method for delivering insoluble material into a living body
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
EP0257368B1 (de) * 1986-08-11 1992-03-25 American Cyanamid Company Zusammensetzungen zur parenteralen Verabreichung und deren Verwendung
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
ATE109941T1 (de) * 1987-04-06 1994-09-15 Endocon Inc Durch schnellschmelzen hergestellte medizinische implantate.
US4892734A (en) * 1987-04-06 1990-01-09 Endocon, Inc. Dispensing paste for forming medicinal pellets
AU4369589A (en) * 1988-10-27 1990-05-03 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
FR2663223B1 (fr) * 1990-06-14 1994-12-02 Af Aplicaciones Far Lab Forme galenique parenterale.

Also Published As

Publication number Publication date
CZ286199B6 (cs) 2000-02-16
ES2068592T3 (es) 1995-04-16
DE69107026T2 (de) 1995-08-31
NO302927B1 (no) 1998-05-11
CS181591A3 (en) 1992-06-17
PL167177B1 (pl) 1995-08-31
KR0157438B1 (ko) 1998-11-16
IL98458A (en) 1995-12-31
CN1058608C (zh) 2000-11-22
AU8066791A (en) 1992-01-07
PT97976B (pt) 1998-11-30
BR9105782A (pt) 1992-08-18
AU643540B2 (en) 1993-11-18
UY23239A1 (es) 1991-07-12
CA2064861C (fr) 2000-08-01
NZ238543A (en) 1993-08-26
SK279867B6 (sk) 1999-04-13
US5643604A (en) 1997-07-01
FR2663224A1 (fr) 1991-12-20
NO920576D0 (no) 1992-02-13
EP0487674B1 (de) 1995-01-25
IE69172B1 (en) 1996-08-07
HUT61458A (en) 1993-01-28
CA2064861A1 (fr) 1991-12-15
PH30243A (en) 1997-02-05
TNSN91047A1 (fr) 1992-10-25
FI920661A0 (fi) 1992-02-14
BG61178B1 (bg) 1997-02-28
DK0487674T3 (da) 1995-06-26
TW205511B (de) 1993-05-11
EP0487674A1 (de) 1992-06-03
ZA914549B (en) 1992-03-25
RO110198B1 (ro) 1995-11-30
FI107697B (fi) 2001-09-28
ATE117546T1 (de) 1995-02-15
JP2690398B2 (ja) 1997-12-10
HU9200775D0 (en) 1992-05-28
GR3015809T3 (en) 1995-07-31
IE912018A1 (en) 1991-12-18
JPH05501268A (ja) 1993-03-11
NO920576L (no) 1992-04-08
IL98458A0 (en) 1992-07-15
HU219461B (hu) 2001-04-28
PL290678A1 (en) 1992-06-26
FR2663224B1 (fr) 1995-01-20
PT97976A (pt) 1992-04-30
RU2095055C1 (ru) 1997-11-10
KR920702212A (ko) 1992-09-03
WO1991019485A1 (fr) 1991-12-26
CN1057960A (zh) 1992-01-22

Similar Documents

Publication Publication Date Title
DE69107026T2 (de) Injizierbare galenische retardzubereitung.
ZA93929B (en) A process for the preparation of biologically active materialcontaining polymeric microcapsules.
IT8620799A0 (it) Composizioni farmacueutiche adattivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo, eprocedimento per prepararle.
PL301973A1 (en) Method of obtaining solution of chemical compounds and method of obtaining n-cyclic and n,n'-bicyclic ureas
EP0414007A3 (en) A novel arginine deiminase, its manufacturing method and an anti-cancer agent containing this enzyme as an effective ingredient
ITMI910450A0 (it) Processo per la sintesi allo stato solido di polimeri dell'acido lattico e prodotti cosi' ottenuti
HU9303749D0 (en) 2,4-substituted 5-(n-substituted-sulfamoyl)-benzoyl-guanidines, process for producing them, their use as medicine or diagnosticum and pharmaceutical compositions containing them
DE59609208D1 (de) Herstellung von Mischkristallen und festen Lösungen von 1,4-Diketopyrrolopyrrolen
DE69311734D1 (de) Depolymerisation von nylon 66 (und gegebenenfalls nylon 6) zur herstellung von hexamethylendiamin (und caprolactam)
HUT54358A (en) Process for producing substituted 1,3,5-triazinetrione derivatives and medical compositions comprising such compounds as active ingredient
HUT45972A (en) Process for production of derivatives of subsituated amin-methil-5,6,7,8-tetrahydronaphtil-oxi-acetic acid, of medical compositions containing such substances and also of the intermediers
HUT53773A (en) Antidotums containing substituted 1,8-naphtiridine derivatives as aktive components and process for producing the active components
HU914066D0 (en) Process for producing tertiary-butyl-oxy-carbonyl-1-thyrosil-peptidoglicane monomer and its 125-i marked derivatives
HUT65253A (en) Process for producing of 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising them
HUT52071A (en) Process for producing 1-amino-alkyl-3-oxy-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-one derivatives and pharmaceutical compositions containing them as active components
HUT45502A (en) Process for producing new 2,6-diamino-3-(halogen-benzyl)-pyridines and pharmaceutics comprising the same as active ingredient
HUT60737A (en) Process for producing new 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same as active ingredient
HUT61776A (en) Process for producing 3' and/or 4' oh-modificated elsamycin derivatives and pharmaceutical compositions containing them as active components
ATE199713T1 (de) Verfahren zur herstellung von halogenid-imiden und ihre verwendung als feuerfestmachende mittel
Maksak et al. Contact of Elements of Alloys With" Shape Memory"
HU907627D0 (en) Process for producing diamides of pyridine-2,4 and 2,5-dicarboxylic acid and pharmaceutical preparatives containing these compounds as active substances
PL301415A1 (en) Novel derivatives of phenyloacetic acid, method of obtaining such derivative, pharmaceutical and method of obtaining /2-(2,6-dichloroanilline)phenylo/-acetoxyacetic acid
CS22989A2 (en) Method of epsilon-caprolactam's modified polymers preparation
HU902109D0 (en) Process for producing 4-(4'-halogenous-phenyl)-2-methyl-1,2,3,4-tetrahydro-isoquinoline derivatives and pharmaceutical preparatives containing these compounds as active substance
CS450189A1 (en) Method of caprolactam's cyclic oligomers containing mixtures thermical depolymerization

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee